Medicare Milestone for Envisia Genomic Classifier
First test for improved IPF diagnosis receives draft local coverage determination through the MolDx program.
Read More
Search Results for: lung cancer
Researchers Demonstrate Prognostic Value of VeriStrat Testing for Patients with Advanced Lung Cancer
In a study of 1,048 patients, researchers found that the VeriStrat test is a significant predictor of patient outcomes, independent of mutation status, treatment received, and other clinical variables.
Read More
Kidney Cancer Study Puts Circulating Tumor DNA Assay to Test
The study will examine whether Natera’s circulating tumor DNA assay can distinguish between recurring and nonrecurring cases of kidney cancer.
Read MoreOGT Expands Custom NGS Cancer Panel Content and Readies Enhanced Software for Release
The expanded SureSeq myPanel next-generation sequencing custom cancer panel now covers 120 fully optimized cancer-related genes.
Read More
Precipio Launches Liquid Biopsy DNA Enrichment Sales in Europe
The company anticipates a $10 million annual European market, with $1 million in annual addressable sales potential from its local partner it Italy.
Read More